Role of Obesity in the Progression of Diabetic Nephropathy in Patients with Diabetes Mellitus (Literature Review)
Journal Title: Міжнародний ендокринологічний журнал - Year 2016, Vol 6, Issue 78
Abstract
The prevalence of obesity has risen proportionally to epidemic and continues to be a major health problem worldwide. The high prevalence of obesity is closely associated with the increased incidence of chronic diseases, such as diabetes mellitus, hypertension and cardiovascular diseases. Obesity, as well as diabetes mellitus and hypertension, is the main cause of chronic kidney disease and end-stage renal disease. The presence of at least one of these risk factors increases the overall risk of developing the disease. The pathophysiology of diabetic nephropathy and renal diseases associated with obesity are nearly identical. In addition, they lead to the development of successive changes, from an increase in glomerular filtration rate and intraglomerular capillary pressure to glomerular hypertrophy and microalbuminuria. Increased systolic blood pressure further aggravates the process and causes the disease progression to proteinuria, nodular glomerulosclerosis, tubulointerstitial renal disease and reduced glomerular filtration rate leading to the development of end-stage renal failure. White adipose tissue — not only a fat storage organ, but also is now recognized as a dynamic tissue involved in the production of adipokines, such as leptin, adiponectin, etc. The balance between these adipokines allows adipose tissue to regulate appetite, food intake, glucose clearance, energy expenditure. Imbalance in obesity stimulates an inflammatory environment and leads to insulin resistance. Kidney disease related to obesity is associated with disorders of renal hemodynamics, dysfunction of endothelium and podocytes, damage to the glomerular basement membrane, mesangial expansion, tubular atrophy, interstitial fibrosis and progressive decline in renal function (increased albuminuria and decreased glomerular filtration rate) leading to the development of end-stage renal disease. Nevertheless, there is no clear understanding of the mechanisms, by which the obesity alone or in conjunction with type 2 diabetes and hypertension contributes to the development and/or progression of chronic kidney disease and end-stage renal failure.
Authors and Affiliations
S. U. Аhmedova, M. N. Daminova, Z. S. Kadyrova
Keywords
Related Articles
- EP ID EP177966
- DOI 10.22141/2224-0721.6.78.2016.81865
- Views 43
- Downloads 0
Optimization of Diagnosis and Treatment of Patients with Complicated Myocardial Infarction in Type 2 Diabetes Mellitus
The influence of combined treatment with the additional including of systemic enzyme therapy on the clinical manifestations of postinfarction syndrome, cardiohemodynamic parameters and free radical lipid peroxidation ind...
Experience of Using Pentosan Polysulfate SP 54 in Patients with Diabetic Foot Syndrome
Diabetic foot — a complex of anatomical and functional changes in the feet caused by diabetic neuropathy leading to osteoarthropathy and angiopathy, against which purulent necrotic processes may develop. Microangiopathy...
Role of Training System in the Formation of Active Motivation to Self-Management in Patients with Diabetes Mellitus
The article presents research data confirming the importance of self-management training to achieve and maintain long-term compensation in patients with diabetes mellitus. There are provided an analysis of the literature...
The state of cognitive functions in patients with adult onset type 2 diabetes mellitus depending on sex, age and level of education
Background. According to the meta-analysis of studies, patients with diabetes mellitus (DM) have worse memory performance, information processing speed, executive functions compared to patients without DM. The level of e...
Peculiarities of bronchial asthma persistence in schoolchildren depending on adrenal cortisol-producing function
Background. Nowadays, inhalation glucocorticosteroids (IGCS) play a leading role in the treatment of bronchial asthma (BA), both on the stage of achieving and maintaining a complete control of clinical signs of the disea...